Contact system activation in severe infectious diseases.
about
The immunopathology of sepsis: pathogen recognition, systemic inflammation, the compensatory anti-inflammatory response, and regulatory T cellsComplement-Coagulation Cross-Talk: A Potential Mediator of the Physiological Activation of Complement by Low pHHost defense peptides of thrombin modulate inflammation and coagulation in endotoxin-mediated shock and Pseudomonas aeruginosa sepsisFactor XI-deficient mice display reduced inflammation, coagulopathy, and bacterial growth during listeriosisPlasma kallistatin in critically ill patients with severe sepsis and septic shock.Plasma kallistatin levels in patients with severe community-acquired pneumonia.Cleavage of kininogen and subsequent bradykinin release by the complement component: mannose-binding lectin-associated serine protease (MASP)-1A peptide of heparin cofactor II inhibits endotoxin-mediated shock and invasive Pseudomonas aeruginosa infection.Neutrophil elastase causes tissue damage that decreases host tolerance to lung infection with burkholderia species.The TFPI-2 derived peptide EDC34 improves outcome of gram-negative sepsis.Oversulfated chondroitin sulfate binds to chemokines and inhibits stromal cell-derived factor-1 mediated signaling in activated T cells.Exploration of the host haemostatic system by group A streptococcus: implications in searching for novel antimicrobial therapiesInteraction of Bacteroides fragilis and Bacteroides thetaiotaomicron with the kallikrein-kinin systemKinin release from human kininogen by 10 aspartic proteases produced by pathogenic yeast Candida albicansPredictive value of serum bradykinin and desArg9-bradykinin levels for chemotherapeutic responses in active tuberculosis patients: A retrospective case series.Polyphosphate suppresses complement via the terminal pathway.Kinin system activation in vasculitis.The enhanced permeability retention effect: a new paradigm for drug targeting in infection.Interaction between Paracoccidioides brasiliensis conidia and the coagulation system: involvement of fibrinogen.The emerging roles of mannose-binding lectin-associated serine proteases (MASPs) in the lectin pathway of complement and beyond.Single-chain factor XII: a new form of activated factor XII.Leptospira Infection Interferes with the Prothrombinase Complex Assembly during Experimental Leptospirosis.Factor XI deficiency enhances the pulmonary allergic response to house dust mite in mice independent of factor XII.Streptococcus pyogenes triggers activation of the human contact system by streptokinase.Protective roles for fibrin, tissue factor, plasminogen activator inhibitor-1, and thrombin activatable fibrinolysis inhibitor, but not factor XI, during defense against the gram-negative bacterium Yersinia enterocolitica.Activation of the contact system at the surface of Fusobacterium necrophorum represents a possible virulence mechanism in Lemièrre's syndrome.Streptococcal surface proteins activate the contact system and control its antibacterial activity.C1-inhibitor efficiently inhibits Escherichia coli-induced tissue factor mRNA up-regulation, monocyte tissue factor expression and coagulation activation in human whole blood.Streptococcus gallolyticus subsp. gallolyticus endocarditis isolate interferes with coagulation and activates the contact system.Interaction of the Human Contact System with Pathogens-An Update.Stimulation of blood mononuclear cells with bacterial virulence factors leads to the release of pro-coagulant and pro-inflammatory microparticles.Cell Receptor and Cofactor Interactions of the Contact Activation System and Factor XI.Bacterial Abuse of Mammalian Extracellular Proteases during Tissue Invasion and Infection
P2860
Q27022093-988D0769-1D7A-4E2D-AEB7-CB79B96074C0Q27027361-E1797394-697B-4BA2-8B48-929084A6C3E7Q27331817-1753AF9B-8F43-4D4E-BF9B-FA8FF6C895CEQ33397684-2B6F6E31-6D50-4898-8DC1-EAAAADBFA1B5Q33725117-8258EE27-61F6-4557-9F8B-8A6860EDED0EQ33752812-579E22D4-A2D9-4A3E-9D47-4E2202D9CA33Q33916226-8E7C5D33-B5A7-4A9D-8495-81B5DFC65D89Q33927961-D986F7AE-DF08-42CA-9881-FEC65192793BQ34105441-02C03DD9-0006-4987-A203-CCCFC84B49A7Q35067228-9388CAA4-CD52-4B40-A47E-042D86D505EFQ35144316-9AE1D14C-CB2A-4D22-B519-94438B5EBEB1Q35149917-CE424632-5C48-4D25-A472-0F94E3874867Q35199118-0DDF44A5-509E-4A86-9D4F-C329EC6BF415Q35603104-4495EEA3-60AC-45E8-B93C-62057C9A2445Q37531394-5C44F67E-1F67-4E4B-AADD-1711F382B5D8Q37535268-933733F0-1ACD-4F1C-98F4-40F1434F19E4Q37852784-AD862803-D66A-4A11-9EC1-1E6231446295Q38051263-25E08CEA-A488-489D-882F-D2CAB93ED623Q38567474-A9E2D894-D225-48B8-81F0-FF0FB29D7DA4Q38991005-E530260B-E1C9-48D6-B9DF-0080551DC256Q39366435-F12BEA59-0BAA-4298-8633-F4429325EC28Q40255062-21B9F66F-34F2-4A3B-8330-301916843A05Q40425828-18FEE800-1D57-4D39-B8E8-7C12B5021991Q40925491-ECB0FBE7-D309-409A-BB28-78D63E199DDCQ41428336-5B31AB52-E217-4B78-9157-A89A82300EA4Q41964436-7F34CA03-31AD-450A-91FC-97BB86BDDBC0Q42187361-9E955ED9-12A4-4F42-9F78-5FE555AEC309Q44198286-046C0758-790B-41EC-A640-1F09B79A4FF3Q47599757-07824DF8-EE34-4F04-9E4F-3DE30A165A97Q52726746-FF26E2E2-067F-4E93-ADEE-914AA88332D7Q53216740-8E0051EB-5E52-4CB1-B2B4-FCD36D12C5BFQ55052361-E9285209-0FD0-47D3-89FD-BB38BBAB4709Q57983437-8AB84F27-AED0-4DC2-B6FF-6265D1ECC00F
P2860
Contact system activation in severe infectious diseases.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Contact system activation in severe infectious diseases.
@ast
Contact system activation in severe infectious diseases.
@en
Contact system activation in severe infectious diseases.
@nl
type
label
Contact system activation in severe infectious diseases.
@ast
Contact system activation in severe infectious diseases.
@en
Contact system activation in severe infectious diseases.
@nl
prefLabel
Contact system activation in severe infectious diseases.
@ast
Contact system activation in severe infectious diseases.
@en
Contact system activation in severe infectious diseases.
@nl
P1476
Contact system activation in severe infectious diseases.
@en
P2093
Sonja Oehmcke
P2860
P2888
P304
P356
10.1007/S00109-009-0564-Y
P577
2010-02-01T00:00:00Z
P6179
1027303789